Myriad Genetics, Inc. MYGN
Set alert
At close · Oct 30
After hours · Oct 30, 7:51 PM ET
- YTD
- +3.25%
- 1 year
- -20.13%
- Open
- 6.51
- Prev close
- 6.67
- Mkt cap
- 607.38M
- Vol
- 1.50M
- Avg vol
- 2.64M
- EPS
- -1.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.29
- High
- 6.66
- Forward P/E
- 71.53
- Beta
- 1.89
- Short ratio
- 4.83
- Inst. own
- 103.89%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 13.32
- 200-d avg
- 21.11
- 1y target
- 19.41
Discussion (3)
Sign in to join the discussion
Loads of insider sellling. But stock keeps climbing.
DB Berry MYGN 7 years ago #2$MYGN Stock price has been crawling up slowly for the last 5 days. Accumulating and leading up to Sept 10. This stock may kaboom again then.. “Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the Morgan Stanley Global Healthcare Conference at 8:35 a.m. EDT on September 10, 2019, in New York City.”
http://www.globenewswire.com/news-release/2019/08/30/1908990/0/en/Myriad-Genetics-to-Present-at-the-2019-Morgan-Stanley-Global-Healthcare-Conference.html
DB Berry MYGN 7 years ago #3$MYGN Will bounce back massively soon.
Too many leads and great news out there for MYGN to weather the storm then bounce back up biglyyy.. :)
Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention.
https://www.streetinsider.com/Globe+Newswire/Myriad+Applauds+the+U.S.+Preventive+Services+Task+Force%C2%A0Recommendation+on+BRCA-Related+Cancer+Prevention/15843821.html